The point is that the doses listed on the patch (where they're listed at all Kind doesn't disclose specific quantities for several of them) are nowhere near the levels shown to be useful in studies, and even those amounts almost certainly aren't getting through your skin
Originally developed for the treatment of type 2 diabetes, these peptide-based drugs are now at the forefront of both metabolic disease management and obesity treatment, driving unprecedented market growth and industry attention
Tirzepatide has shown the largest results so far, with average reductions ranging from 15% to nearly 21% over 72 weeks, depending on dose
The Gler paper provides a mechanistic substrate for those observations
Your athlete should be working with their doctor and other qualified experts, such as a registered dietitian and their coach, to determine appropriate fueling and training protocols while using the medication
Now it says its clients have been doing the same, marking a notable Evernorth GLP-1 coverage downtick across the companys pharmacy benefits business